Pacific Edge says it's on track after posting 1H loss; shares jump

Pacific Edge says it's on track after posting 1H loss; shares jump
By Tina Morrison Nov. 28 (BusinessDesk) - Pacific Edge, which makes and markets bladder cancer tests, said its first half loss was unchanged from the year earlier period as increased revenues were channelled into development and marketing of its products, in line with its plans. The shares jumped to a seven-week high. The Dunedin-based company posted a net loss of $4.73 million in the six months ended Sept. 30, little changed from the loss of $4.76 million in the year earlier period, it said in a statement. Total revenue soared to $1.6 mi...